6 results
The aim of this study is to evaluate the effect of a single oral dose of TW001 on oxidative stress and pharmacokinetics with and without food. Dosing with an oral solution is considered to have major advantages over iv dosing in a chronic condition…
To evaluate the long-term safety of FAB122 in patients with ALS.
The objective of the study is to assess the long-term safety and efficacy of intravenous ATB200 co-administration with oral AT2221 in adult subjects with late-onset Pompe disease.
To assess the effect of treatment with 100 mg of FAB122 (edaravone) on disease progression in patients with ALS.
Primary objective:The main objective of the present trial are:• to evaluate the effect of TW001 on oxidative stress biomarkers• to evaluate the safety of TW001 in patients with Alzheimer*s DiseaseSecondary objective:The secondary objective of the…
To assess the effect of treatment with 100 mg of FAB122 (edaravone) on disease progression in patients with ALS.